PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
Clinical trial NCT03423199 · UNKNOWN
Trial details
- NCT number
- NCT03423199
- Sponsor
- National Cancer Center, Japan
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-09
- Primary completion
- 2025-09-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.